S1 Biopharma is evaluating partnerships, collaborations and out-licensing deals that will enable the company to rapidly advance its sexual dysfunction franchise as well as to accelerate the path to commercialization for its drug candidates in the U.S. and internationally.

For additional information please contact:

John F. Kaufmann, M.B.A., CFO, S1 Biopharma
Tel: +201-283-9050